Treatment of T Angina reatment of By Ali Alalawi

Size: px
Start display at page:

Download "Treatment of T Angina reatment of By Ali Alalawi"

Transcription

1 Treatment of Angina By Ali Alalawi

2 Determinants of Oxygen Demand Need to improve ratio of: Coronary blood flow / cardiac work Or Cardiac O2 Supply / Cardiac Requirement

3 Coronary Circulation vs Other Circulation Most tissues can increase O2 extraction with demand Heart extracts near maximal amount of O2 at rest. Therefore can only increase O2 delivery by increasing coronary blood flow

4 Goals of Treatment Antianginal drugs may relieve attacks of acute myo- cardial ischemia by: 1. Increasing myocardial oxygen supply or 2. Decreasing myocardial oxygen demand or 3. Both.

5 Three groups of pharmacological agents have been shown to be effective in reducing the frequency, severity, or both of primary or secondary angina. These agents include : 1. The nitrates. 2. B-adrenoceptor antagonists. 3. Calcium entry blockers.

6 Improving supply/demand ratio 1. Relaxation of resistance vessels (small arteries and arterioles) TPR BP Afterload (Nitrates, calcium channel blockers and beta-blockers) 2. Relaxation of capacitance vessels (veins and venules) Venous return, heart size, Preload (Nitrates and calcium channel blockers) 3. Blockade or attenuation of sympathetic influence on the heart demand Contactility, HR, O2 (Beta-blockers) 4. Coronary Dilation - Important mechanism for relieving vasospastic angina O2 supply (Nitrates)

7 The Nitrates: Proposed mechanism by which nitroglycerin and the organic nitrates produce relaxation in vascular smooth muscle. Nitrates induce endothelial cells to release NO or a nitrosothiol which lead to activates the enzyme guanylate cyclase, which causes the generation of cyclic guanosine monophosphate (GMP), Lead to producing a decrease in cytosolic free calcium. The end result is vascular smooth muscle relaxation.

8 N I T R A T E S

9 Nitrates Common Available Agents Isorbide dinitrate Isorbide mononitrate Long-acting transdermal patches Nitroglycerin sl

10 Nitrates Side Effects Headache Flushing Palpitations Tolerance

11 Nitrates Reducing Tolerance Smaller doses Less frequent dosing Avoidance of long-acting formulations unless a prolonged nitrate-free interval is provided Build-in a nitrate-free interval 8-12 hours

12 B-adrenoceptor antagonists. Common Available Agents : Propranolol Atenolol Metoprolol Nadolol Timolol

13 Mechanism of action of ß-blockers Activation of ß adrenoceptors on heart Cardiac Output Peripheral resistance B 1BLOCKERS Decrease in blood pressure Angiotension II Renin aldosterone Sodium, water retention Blood volume

14 ß-blockers

15 ß-blockers: Decrease myocardial oxygen consumption Blunt exercise response Beta-one drugs have theoretical advantage Try to avoid drugs with intrinsic sympathomimetic activity First line therapy in all patients with angina if possible

16 Side effects: Bronchospasm Diminished exercise capacity Negative inotropy Sexual dysfunction Bradyarrhythmia Masking of hypoglycemia

17 Calcium entry blockers. Mechanism of action: 1. They block voltage-dependent L-type calcium channels relaxation of smooth muscle vasodilation reduce peripheral vascular resistance reduction of BP. 2. Block platelet aggregation. Uses: particularly effective in the prophylaxis of coronary vasospasm or variant angina. These compounds are used in the chronic treatment of secondary angina. Two members of this group: verapamil Diltiazem Also have been approved for use in the therapy of certain supraventricular tachyarrhythmias

18 alcium blockers. Ca

19 Side Effects: Palpitations Headache Ankle edema Gingival hyperplasia

20 Drug Choices in Angina A. Effort: nitrates, calcium blockers, beta blockers B. Variant: nitrates, calcium blockers, beta blockers, aspirin, anticoagulants, thrombolytics Aims in the use of antianginal drugs: a. Treatment of acute attack - nitroglycerin very effective (i.e., sublingual, oral spray) b. Short term prophylaxis - taking nitroglycerin prior to anticipated physical or emotional stress may prevent attack c. Long term prophylaxis - objective is to reduce frequency of anginal attacks. Many options are now availabile i.e. Ca blockers, ß- blockers, aspirin, anticoagulants, thrombolytics

21 Qustions

22

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth University

More information

Pharmacotherapy of Angina Pectoris

Pharmacotherapy of Angina Pectoris Pharmacotherapy of Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth

More information

Pharmacotherapy of Angina Pectoris

Pharmacotherapy of Angina Pectoris Pharmacotherapy of Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth

More information

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction Pharmacology Ezra Levy, Pharm.D. ANGINA PECTORIS A. Definition angina pectoris is a symptom of myocardial ischemia in the absence of infarction angina usually implies severe chest pain or discomfort during

More information

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs) Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,

More information

Drug Treatment of Ischemic Heart Disease

Drug Treatment of Ischemic Heart Disease Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant

More information

Antianginal Drugs. Garrett J. Gross THE THERAPEUTIC OBJECTIVES IN THE USE OF ANTIANGINAL DRUGS

Antianginal Drugs. Garrett J. Gross THE THERAPEUTIC OBJECTIVES IN THE USE OF ANTIANGINAL DRUGS 17 Antianginal Drugs Garrett J. Gross DRUG LIST GENERIC NAME PAGE GENERIC NAME PAGE Atenolol 201 Diltiazem 203 Isosorbide dinitrate 197 Isosorbide mononitrate 197 Metoprolol 201 Nadolol 201 Nitroglycerin

More information

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial Angina Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial ischemia and pain as well as prevention of myocardial

More information

Drug Treatment of Ischemic Heart Disease

Drug Treatment of Ischemic Heart Disease Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan November, 2017 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant

More information

Antianginal Drugs 18 I. OVERVIEW II. TYPES OF ANGINA

Antianginal Drugs 18 I. OVERVIEW II. TYPES OF ANGINA Antianginal Drugs 18 I. OVERVIEW Atherosclerotic disease of the coronary arteries, also known as coronary artery disease or ischemic heart disease, is the most common cause of mortality around the world.

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

DRUGS USED IN ANGINA PECTORIS

DRUGS USED IN ANGINA PECTORIS DRUGS USED IN ANGINA PECTORIS Course: Integrated Therapeutics 1 Lecturer: Dr. E. Konorev Date: November 16, 2010 Materials on: Exam #7 Required reading: Katzung, Chapter 12 1 TYPES OF ISCHEMIC HEART DISEASE

More information

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.

More information

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood

More information

Angina Pectoris Dr. Shariq Syed

Angina Pectoris Dr. Shariq Syed Angina Pectoris Dr. Syed 1 What is Angina Pectoris (AP)? Commonly known as angina is chest pain often due to ischemia of the heart muscle, Because of obstruction or spasm of the coronary arteries 2 What

More information

Drug Treatment of Ischemic Heart Disease

Drug Treatment of Ischemic Heart Disease Drug Treatment of Ischemic Heart Disease 1 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant Angina Primary Angina Unstable Angina Myocardial Infarction 2 3 Secondary Angina Primary

More information

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensive drugs SUMMARY Made by: Lama Shatat Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone

More information

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples

More information

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit

More information

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel

More information

Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris

Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris Br. J. clin. Pharmac. (1987), 23, 391-396 Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris J. V. SHERIDAN, P. THOMAS, P. A. ROUTLEDGE & D. J. SHERIDAN Departments

More information

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI 3. Vasodilators Drugs which dilate blood vessels ( decrease peripheral vascular resistance) by acting on smooth muscle cells through non-autonomic mechanisms:

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Initial Medical and Surgical Management of Unstable Angina Pectoris

Initial Medical and Surgical Management of Unstable Angina Pectoris Clin. Cardiol. 2. 311-316 (I979) G. Witzstrock Publishing House. Inc. Editorial Initial Medical and Surgical Management of Unstable Angina Pectoris Introduction The purpose of this report is to review

More information

Nitroglycerin and Heparin Drip Interfacility Protocols

Nitroglycerin and Heparin Drip Interfacility Protocols Nitroglycerin and Heparin Drip Interfacility Protocols EMS Protocol This protocol applies to nitroglycerin and Heparin drips that are initiated at the transferring facility prior to transport and are not

More information

Objectives. Pharmacological Management of Chronic Coronary Artery Disease. Epidemiology

Objectives. Pharmacological Management of Chronic Coronary Artery Disease. Epidemiology Pharmacological Management of Chronic Coronary Artery Disease Objectives Review the principles of myocardial oxygen supply and demand Review the mechanism of action, adverse effects, and clinical use of

More information

Chapter (9) Calcium Antagonists

Chapter (9) Calcium Antagonists Chapter (9) Calcium Antagonists (CALCIUM CHANNEL BLOCKERS) Classification Mechanism of Anti-ischemic Actions Indications Drug Interaction with Verapamil Contraindications Adverse Effects Treatment of Drug

More information

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

CARDIAC REHABILITATION PROGRAMME:- MEDICATION CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to

More information

Hypertension. Penny Mosley MRPharmS

Hypertension. Penny Mosley MRPharmS Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines

More information

Structure and organization of blood vessels

Structure and organization of blood vessels The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins

More information

ANTIANGINAL AGENTS AND VASODILATORS (1)

ANTIANGINAL AGENTS AND VASODILATORS (1) ANTIANGINAL AGENTS AND VASODILATORS (1) Context Heart diseases are grouped into three major disorders: Cardiac failure or contractile dysfunction. Ischemic heart disease (with angina as its primary symptom)

More information

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

Treatment of Essential Hypertension

Treatment of Essential Hypertension 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology

More information

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output. Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries

More information

CHAPTER-I MYOCARDIAL INFARCTION

CHAPTER-I MYOCARDIAL INFARCTION CHAPTER-I MYOCARDIAL INFARCTION Definition A myocardial infarction, more commonly known as MI or acute myocardial infarction (AMI) or heart attack is a condition where there is interruption of blood supply

More information

Section 3, Lecture 2

Section 3, Lecture 2 59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect

More information

MANAGEMENT OF CHRONIC STABLE ANGINA IN CURRENT PRACTICE

MANAGEMENT OF CHRONIC STABLE ANGINA IN CURRENT PRACTICE Dr.A.M.Thirugnanam, MD, MSCIP, FSCAI, PhD Senior Interventional Cardiologist Ipcard Cardiac Care Center, Hyderabad,Date;10-01-12 MANAGEMENT OF CHRONIC STABLE ANGINA IN CURRENT PRACTICE Brain twisters What

More information

Cardiovascular drugs

Cardiovascular drugs chapter 13 Cardiovascular drugs Cardiovascular drugs act on the heart or blood vessels to control the cardiovascular system. They are used to treat a variety of conditions from hypertension to chronic

More information

Managing IHD and acute Myocardial Infarction

Managing IHD and acute Myocardial Infarction Managing IHD and acute Myocardial Infarction In Ireland- 1 out of every 10 deaths ( 22% of all premature deaths) in 2006 were due to CVD 30,000 15,000 0 1998 1999 2000 2001 2002 2003 2004 2005 2006 Source

More information

Categories of HTN. Overview of Hypertension. Types of Hypertension

Categories of HTN. Overview of Hypertension. Types of Hypertension Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is

More information

Cardiovascular Pharmacotherapy

Cardiovascular Pharmacotherapy Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin

More information

Make you feel better Make you live longer

Make you feel better Make you live longer Drugs and Devices for Women with Heart Disease Sharonne N. Hayes MD, FACC Director, Women s Heart Clinic Mayo Clinic Rochester, MN CP986192-1 CP1045209-2 Goals of Medical Treatments for Heart Disease Make

More information

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction. s Aspirin Platelet aggregation inhibitor. Anti-inflammatory agent and an inhibitor of platelet function. Useful agent in the treatment of various thromboembolic diseases such as acute myocardial infarction.

More information

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker. LESSON ASSIGNMENT LESSON 8 Adrenergic Blocking Agents. TEXT ASSIGNMENT Paragraphs 8-1 through 8-5. LESSON OBJECTIVES 8-1. Given a group of statements, select the statement that best describes one of the

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

Results of Ischemic Heart Disease

Results of Ischemic Heart Disease Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias

More information

Dr. Vishaal Bhat. anti-adrenergic drugs

Dr. Vishaal Bhat. anti-adrenergic drugs Dr. Vishaal Bhat anti-adrenergic drugs Divisions of human nervous system Human Nervous system Central Nervous System Peripheral Nervous System Autonomic Nervous System Nervous system Includes neurons and

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

*For a more complete review of each area, please refer to the recently published ACC/AHA /ACP-ASIM Chronic Stable Angina Guidelines

*For a more complete review of each area, please refer to the recently published ACC/AHA /ACP-ASIM Chronic Stable Angina Guidelines 1 of 7 3/31/2010 3:29 PM *For a more complete review of each area, please refer to the recently published ACC/AHA /ACP-ASIM Chronic Stable Angina Guidelines. 1 1. Aspirin Since t he m ajority of c linical

More information

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias 1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should

More information

Pharmacology of the Sympathetic Nervous System II

Pharmacology of the Sympathetic Nervous System II Pharmacology of the Sympathetic Nervous System II Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia

More information

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5 ANTIHYPERTENSIVE AGENTS AND VASODILATORS Lecture 5 Hypertension Blood pressure BP = CO x PVR n Interaction between autonomic nervous system, cardiovascular system and renal system Normal: 110/70 Prehypertension

More information

Evidence Supporting Post-MI Use of

Evidence Supporting Post-MI Use of Addressing the Gap in the Management of Patients After Acute Myocardial Infarction: How Good Is the Evidence Supporting Current Treatment Guidelines? Michael B. Fowler, MB, FRCP Beta-adrenergic blocking

More information

Drug Profiles Professional Responder

Drug Profiles Professional Responder Entonox Classification Medical Gas Entonox (50% oxygen 50% nitrous oxide) Effects Potent analgesic, weak anesthetic Onset Rapid Peak Immediate Indications Relief of moderate to severe pain Cardiac-related

More information

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually

More information

β adrenergic blockade, a renal perspective Prof S O McLigeyo

β adrenergic blockade, a renal perspective Prof S O McLigeyo β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant

More information

Autonomic Pharmacology

Autonomic Pharmacology Autonomic Pharmacology ADRENERGIC RECEPTOR BLOCKERS Adrenergic-receptor antagonists block the effects of sympathetic stimulation and adrenergic agonists mediated through - and -receptors. Adrenergic receptor

More information

Management of Stable Angina Drugs, Stents and Devices for Coronary Bypass Surgery

Management of Stable Angina Drugs, Stents and Devices for Coronary Bypass Surgery Management of Stable Angina Drugs, Stents and Devices for Coronary Bypass Surgery a report by Udho Thadani Professor of Medicine, Division of Cardiology, Oklahoma University Health Sciences Center (OUHSC)

More information

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body

More information

Atrial fibrillation in the ICU

Atrial fibrillation in the ICU Atrial fibrillation in the ICU Atrial fibrillation Preexisting or incident (new onset) among nearly one in three critically ill patients Formation of arrhythogenic substrate usually fibrosis (CHF, hypertension,

More information

Pharmacology - Problem Drill 11: Vasoactive Agents

Pharmacology - Problem Drill 11: Vasoactive Agents Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular

More information

7/21/2017. Learning Objectives. Current Cardiovascular Pharmacology. Epinephrine. Cardiotonic Agents. Epinephrine. Epinephrine. Arthur Jones, EdD, RRT

7/21/2017. Learning Objectives. Current Cardiovascular Pharmacology. Epinephrine. Cardiotonic Agents. Epinephrine. Epinephrine. Arthur Jones, EdD, RRT Learning Objectives Current Cardiovascular Pharmacology Arthur Jones, EdD, RRT Explain the actions, effects, indications, adverse effects, & precautions for agents from the following drug categories Cardiotonic

More information

New Zealand Data Sheet. LYCINATE Sublingual Tablets contain 0.6mg (600mcg) glyceryl trinitrate.

New Zealand Data Sheet. LYCINATE Sublingual Tablets contain 0.6mg (600mcg) glyceryl trinitrate. LYCINATE New Zealand Data Sheet Glyceryl trinitrate 600mcg Tablets Presentation LYCINATE Sublingual Tablets contain 0.6mg (600mcg) glyceryl trinitrate. Uses Actions Glyceryl trinitrate causes smooth muscle

More information

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Ischaemic heart disease. IInd Chair and Clinic of Cardiology Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery

More information

ANTI - ARRHYTHMIC DRUGS

ANTI - ARRHYTHMIC DRUGS ANTI - ARRHYTHMIC DRUGS CARDIAC ACTION POTENTIAL K Out Balance Ca in/k out Na in K Out GENERATION OF ARRHYTHMIAS Four mechanisms of arrhythmia generation; Increased normal automaticity Abnormal automaticity

More information

Metoprolol Succinate SelokenZOC

Metoprolol Succinate SelokenZOC Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic

More information

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018 Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

More information

Cardiac Medications At A Glance

Cardiac Medications At A Glance Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)

More information

Managing Hypertension in the Perioperative Arena

Managing Hypertension in the Perioperative Arena Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT

More information

Hypertensives Emergency and Urgency

Hypertensives Emergency and Urgency Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of

More information

DESCRIPTION Isosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5 dinitrate, an organic nitrate whose structural formula is

DESCRIPTION Isosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5 dinitrate, an organic nitrate whose structural formula is dilatrate -SR (isosorbide dinitrate) Sustained Release Capsules 40 mg RxOnly DESCRIPTION Isosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5 dinitrate, an organic nitrate whose structural formula

More information

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N Coronary Heart Disease Raja Nursing Instructor RN, DCHN, Post RN. BSc.N 31/03/2016 Objectives Define coronary heart disease (CHD). Identify the causes and risk factors of CHD Discuss the pathophysiological

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

CARDIOVASCULAR AGENTS. Dr.P.Valentina, professor, HOD Department of pharmaceutical chemistry SRM college of pharmacy

CARDIOVASCULAR AGENTS. Dr.P.Valentina, professor, HOD Department of pharmaceutical chemistry SRM college of pharmacy CARDIOVASCULAR AGENTS Dr.P.Valentina, professor, HOD Department of pharmaceutical chemistry SRM college of pharmacy System = heart, blood vessels (arteries & veins), Blood Blood rich w/ O2 & nutrients

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Cardiovascular Pharmacology 1. Antihypertensives 2. Antianginal 3. Drugs for HF 4. Antiarrythemics 5. Drugs for Hyperlipoproteniemia

More information

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection CHEST PAIN Dr Susan Hertzberg Emergency Department Prince of Wales Hospital AIMS: To identify causes of chest pain in patients presenting to the ED. To identify and risk stratify patients presenting with

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

Romualdo Belardinelli, MD, FESC Cardiovascular Sciences Department, Lancisi Heart Institute, AOR Ancona, Italy

Romualdo Belardinelli, MD, FESC Cardiovascular Sciences Department, Lancisi Heart Institute, AOR Ancona, Italy Original Article Heart Metab. (2017) 73:13-17 Treating myocardial ischemia in diabetics: drugs, surgery, and stents Romualdo Belardinelli, MD, FESC Cardiovascular Sciences Department, Lancisi Heart Institute,

More information

Staging and Treating Patients with Heart Failure Henry Green, III, DVM, DACVIM Purdue University West Lafayette, IN

Staging and Treating Patients with Heart Failure Henry Green, III, DVM, DACVIM Purdue University West Lafayette, IN Staging and Treating Patients with Heart Failure Henry Green, III, DVM, DACVIM Purdue University West Lafayette, IN There are many different diseases that can cause signs of congestive heart failure(chf)

More information

Chapter 14 Blood Vessels, Blood Flow and Pressure Exam Study Questions

Chapter 14 Blood Vessels, Blood Flow and Pressure Exam Study Questions Chapter 14 Blood Vessels, Blood Flow and Pressure Exam Study Questions 14.1 Physical Law Governing Blood Flow and Blood Pressure 1. How do you calculate flow rate? 2. What is the driving force of blood

More information

The dose for paediatric patients may never exceed the adult dose.

The dose for paediatric patients may never exceed the adult dose. The medication formulary is published by the Pre-Hospital Emergency Care Council (PHECC) to support Emergency First Responders to be competent in the use of medications permitted under Clinical Practice

More information

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle

More information

Treatment of Essential Hypertension

Treatment of Essential Hypertension 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology

More information

Acute coronary syndromes

Acute coronary syndromes Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.

More information

Month/Year of Review: November 2014 Date of Last Review: June 2012 PDL Classes: Anti-anginals, Cardiovascular

Month/Year of Review: November 2014 Date of Last Review: June 2012 PDL Classes: Anti-anginals, Cardiovascular Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2012 Oregon State University. All Rights

More information

PHARMACOLOGICAL PROBLEMS

PHARMACOLOGICAL PROBLEMS PHARMACOLOGICAL PROBLEMS 1. A 69 year old woman suffering from CHF has been treated with.25 mg Digoxin tablet daily for last 3 months. But the heart failure is not controlled adequately. What will be the

More information

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension

More information

Improvement in angina pectoris with alpha adrenoceptor blockade

Improvement in angina pectoris with alpha adrenoceptor blockade Br Heart J 1985; 53: 488-92 Improvement in angina pectoris with alpha adrenoceptor blockade PETER COLLINS, DESMOND SHERIDAN From die Departm of Cardiology, Welsh National School ofmedicine, Cardiff SUMMARY

More information

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Prof dr Aleksandar Raskovic DIRECT VASODILATORS Prof dr Aleksandar Raskovic DIRECT VASODILATORS Direct vasodilators Minoxidil (one of the most powerful peripheral arterial dilators) Opening of KATP channels, efflux of K, lose of Ca and smooth muscle

More information

Management of Myocardial Infarction & Congestive Heart Failure. Dr. Dionne Dames-Rahming

Management of Myocardial Infarction & Congestive Heart Failure. Dr. Dionne Dames-Rahming Management of Myocardial Infarction & Congestive Heart Failure Dr. Dionne Dames-Rahming Myocardial Infarction Objectives of Medical Management Decrease morbidity Reduce further myocardial damage or injury

More information

5 4_part2. Aya Alomoush. Alia Shatanawi

5 4_part2. Aya Alomoush. Alia Shatanawi 5 4_part2 Aya Alomoush Alia Shatanawi 1 P a g e This sheet will talk about vasodilators and an introduction of Ischemic Heart Disease(IHD) which is the topic of lecture 7 and half of lecture 6(starting

More information

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart Cardiovascular Physiology Heart Physiology Introduction The cardiovascular system consists of the heart and two vascular systems, the systemic and pulmonary circulations. The heart pumps blood through

More information